136 related articles for article (PubMed ID: 11995810)
1. Effects of combination chemotherapy with biscoclaurine-derived alkaloid (Cepharanthine) and nimustine hydrochloride on malignant glioma cell lines.
Kono K; Takahashi JA; Ueba T; Mori H; Hashimoto N; Fukumoto M
J Neurooncol; 2002 Jan; 56(2):101-8. PubMed ID: 11995810
[TBL] [Abstract][Full Text] [Related]
2. Specific mTOR inhibitor rapamycin enhances cytotoxicity induced by alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in human U251 malignant glioma cells.
Tanaka K; Sasayama T; Mizukawa K; Kawamura A; Kondoh T; Hosoda K; Fujiwara T; Kohmura E
J Neurooncol; 2007 Sep; 84(3):233-44. PubMed ID: 17390104
[TBL] [Abstract][Full Text] [Related]
3. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
[TBL] [Abstract][Full Text] [Related]
4. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.
Kikukawa Y; Okuno Y; Tatetsu H; Nakamura M; Harada N; Ueno S; Kamizaki Y; Mitsuya H; Hata H
Int J Oncol; 2008 Oct; 33(4):807-14. PubMed ID: 18813795
[TBL] [Abstract][Full Text] [Related]
5. In vitro growth suppression of human glioma cells by a 16-mer oligopeptide: a potential new treatment modality for malignant glioma.
Kono K; Ueba T; Takahashi JA; Murai N; Hashimoto N; Myoumoto A; Itoh N; Fukumoto M
J Neurooncol; 2003 Jun; 63(2):163-71. PubMed ID: 12825820
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM.
Tomicic MT; Meise R; Aasland D; Berte N; Kitzinger R; Krämer OH; Kaina B; Christmann M
Oncotarget; 2015 Oct; 6(32):33755-68. PubMed ID: 26418950
[TBL] [Abstract][Full Text] [Related]
7. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
9. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB.
Seubwai W; Vaeteewoottacharn K; Hiyoshi M; Suzu S; Puapairoj A; Wongkham C; Okada S; Wongkham S
Cancer Sci; 2010 Jul; 101(7):1590-5. PubMed ID: 20412118
[TBL] [Abstract][Full Text] [Related]
10. Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.
Ita M; Halicka HD; Tanaka T; Kurose A; Ardelt B; Shogen K; Darzynkiewicz Z
Cancer Biol Ther; 2008 Jul; 7(7):1104-8. PubMed ID: 18443430
[TBL] [Abstract][Full Text] [Related]
11. An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human glioma cells.
Xu G; Wen X; Hong Y; Du H; Zhang X; Song J; Yin Y; Huang H; Shen G
Int Immunopharmacol; 2011 Nov; 11(11):1844-9. PubMed ID: 21820086
[TBL] [Abstract][Full Text] [Related]
12. Cepharanthine induces apoptosis through the mitochondria/caspase pathway in murine dendritic cells.
Uto T; Toyama M; Yoshinaga K; Baba M
Immunopharmacol Immunotoxicol; 2016 Jun; 38(3):238-43. PubMed ID: 27121492
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
14. Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells.
Yin D; Tamaki N; Kokunai T
J Neurosurg; 2000 Aug; 93(2):289-97. PubMed ID: 10930016
[TBL] [Abstract][Full Text] [Related]
15. Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR.
Katsui K; Kuroda M; Wang Y; Komatsu M; Himei K; Takemoto M; Akaki S; Asaumi J; Kanazawa S; Hiraki Y
Int J Oncol; 2004 Jul; 25(1):47-56. PubMed ID: 15201988
[TBL] [Abstract][Full Text] [Related]
16. Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenografts.
Takano S; Tsuboi K; Matsumura A; Nose T
Neuro Oncol; 2003 Jan; 5(1):1-7. PubMed ID: 12626127
[TBL] [Abstract][Full Text] [Related]
17. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
18. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
[TBL] [Abstract][Full Text] [Related]
19. Effects of biscoclaurine alkaloid cepharanthine on newborn rat skin epidermal and dermal cells.
Ohkura K; Urakami K; Makino S; Terada H
Biol Pharm Bull; 1996 Apr; 19(4):495-500. PubMed ID: 8860946
[TBL] [Abstract][Full Text] [Related]
20. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis.
Furusawa S; Wu J; Fujimura T; Nakano S; Nemoto S; Takayanagi M; Sasaki K; Takayanagi Y
Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):87-97. PubMed ID: 9604850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
